Petros Pharmaceuticals receives Nasdaq deficiency notice for bid price below $1.00

Petros Pharmaceuticals, Inc.

Received Nasdaq letter on June 22, 2022 for bid price <$1.00 over 30 consecutive business days ended June 21, 2022.
Company has 180-day compliance period until December 19, 2022 to regain compliance by closing at $1.00 for 10 consecutive business days.
If not compliant by Dec 19, may qualify for additional 180 days by meeting all other listing standards and effecting reverse stock split if necessary.
No immediate impact on listing; common stock continues trading on Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.